Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

Q. Which pharma organisation has partnered with Merck KGaA and IAVI for development of SARS-CoV-2 neutralizing monoclonal antibodies?

A.            Bharat Biotechnology

B.            Serum Institute

C.            Cipla

D.            Ranbaxy

Answer: Serum Institute